LC
OLMA icon

Lindbrook Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Lindbrook Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41
Closed -$490 – 2874
2024
Q3 		$490 Sell
41
-117
-74% -$1.5K ﹤0.01% 2669
2024
Q2 		$1.71K Hold
158
– – ﹤0.01% 2391
2024
Q1 		$1.79K Hold
158
– – ﹤0.01% 2278
2023
Q4 		$2.22K Hold
158
– – ﹤0.01% 2221
2023
Q3 		$1.95K Hold
158
– – ﹤0.01% 2138
2023
Q2 		$1.43K Buy
+158
New +$954 ﹤0.01% 2283

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Lindbrook Capital's OLMA Position: Q4 2024 in Review

Lindbrook Capital sold out of Olema Pharmaceuticals (OLMA) in Q4 2024, closing a stake of 41 shares — an estimated $490 sold.

Lindbrook Capital first reported a position in OLMA in Q2 2023 and held it in 6 quarters. The position peaked at $2.22K in Q4 2023. 156 funds tracked by Wall St. Rank hold OLMA as of Q4 2024.

  • Lindbrook Capital reported no remaining Olema Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Lindbrook Capital sold 41 Olema Pharmaceuticals shares in Q4 2024, an estimated $490.
  • Lindbrook Capital first reported a position in Olema Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Lindbrook Capital's Olema Pharmaceuticals position peaked at $2.22K in Q4 2023.
  • 156 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2024.

Based on Lindbrook Capital's 13F filing for Q4 2024, filed 6 Feb 2025.